← All trials
NCT05557708
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- Jun 30, 2026
- Completion date
- Jun 30, 2028
- First posted
- Sep 28, 2022
- Last posted
- Sep 28, 2022
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of IowaLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Cancer Institute (NCI)Collaborator
- University of IowaCollaborator
- University of IowaOverall official - principal investigator
- University of IowaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.